CopyMark Law Group
4.9/5
Drawing for SECARNA

USPTO serial 79340689

SECARNA

Reviewed by CopyMark Law Group

Reg. 7220464Status 700Registered
Filing date
Status date
Registration date
Nov 21, 2023
Examiner
HAYS, CANDACE W
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SECARNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

B. Anna McCoy

B. Anna McCoy McCoy Russell LLP1410 NW Johnson St, Ste 201Portland, OR 97209UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Scientific research services in the field of biochemistry, except for the field of cell culture products; Scientific research services in the field of nucleic acids and bioinformatics, in particular molecular- biological work methods, especially antisense technology; design of pharmaceutical active ingredients by means of the aforesaid methods and technologies, also using techniques of bioinformatics; development of pharmaceutical products by means of the aforesaid methods and technologies, also using techniques of bioinformatics, including carrying out associated test and diagnostic methods; information technology (IT) consultancy services for the pharmaceutical and biotechnological industry; consultancy for others in the field of biochemistry and nucleic acids and bioinformatics, including antisense technology, with respect to the development of pharmaceutical products; safety and efficacy testing consultancy for others with respect to the evaluation of safety and efficacy of pharmaceutics; evaluation of pharmaceutical products with respect to their safety and efficacy to assure compliance with industry standardsACTIVE—
045Granting of licenses to others in industrial property rights in the field of scientific research services in the field of biochemistry, except for the field of cell culture products, scientific research services in the field of nucleic acids and bioinformatics, in particular molecular-biological work methods, especially antisense technology, design of pharmaceutical active ingredients by means of the aforesaid methods and technologies, also using techniques of bioinformatics and development of pharmaceutical products by means of the aforesaid methods and technologies, also using techniques of bioinformatics, including carrying out associated test and diagnostic methodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 22, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 22, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 21, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 21, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 21, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 12, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 25, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 25, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 4, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 16, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 16, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 16, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 25, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jul 10, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 14, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 14, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 14, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 14, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
May 9, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2023RFNTREFUSAL PROCESSED BY IB—
Jan 17, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 17, 2023RFRRREFUSAL PROCESSED BY MPU—
Jan 17, 2023DOCKASSIGNED TO EXAMINER—
Nov 7, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 6, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2022DOCKASSIGNED TO EXAMINER—
May 24, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 20, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance